BOSTON, Sept 5, 2024 /PRNewswire/ — Nabla, the leading ambient AI assistant for clinicians, today announced the launch of 31 new languages. Nabla expanded its AI-powered clinical documentation to support additional languages beyond the existing English (US), English (UK), French, and Spanish. The enhancement aims to assist a broader range of physicians who care for patients in various languages, including regional dialects and variations. By introducing these new language options, Nabla hopes to help bridge the language barrier for the 66 million people who do not speak English as their primary language. Nabla now supports 35 international languages.
Exam room language barriers negatively impact the patient-physician relationship, causing confusion, distrust in physicians, a low rate of patient compliance, and poor health outcomes. At the same time, physicians who provide care in multiple languages require expanded access to AI-powered documentation tools that lead to greater efficiency and overall improved patient outcomes. Ineffective communication also has financial implications, where medical errors related to language barriers cost health systems up to $80 billion annually nationwide.
“Supporting physicians with AI assistants like ours that enhance clinical documentation regardless of the language spoken bridges a gap in care delivery and drives forward health equity initiatives,” said Delphine Groll, co-founder and COO, Nabla. “By expanding the languages Nabla captures, we’re advancing care delivery by allowing providers to remain focused on building rapport and trust with the patient and improving the patient experience by generating clear, concise language-specific details and instructions.”
In July 2023, Nabla was the first ambient AI assistant to launch a Spanish-language version to support physician-patient conversations. California-based health systems, including Children’s Hospital Los Angeles, quickly adopted the Spanish-language version, which is used in 8% of the visits conducted with Nabla. Nabla listened closely to its customers and prospects when determining which new language versions to create. For example, prospects and clients based on the West Coast frequently requested Chinese language support to improve communications with their patient population that speaks Chinese languages. All new language versions account for the top languages spoken in the U.S.
Nabla’s generative AI ambiently produces real-time comprehensive clinical notes in the background during physician-patient conversations. The platform also has multi-speaker functionality to ensure guardians and parents are captured when present during the exam. Switching to a different language within Nabla is simple; the provider chooses the specific language before the start of a consultation, and Nabla uses its powerful ambient AI to create detailed clinical notes in English and patient instructions in the selected language. Providing patient instructions in their preferred language improves patient engagement and treatment adherence, increases trust in the healthcare industry, and ultimately better patient health outcomes.
About Nabla
Nabla is the leading ambient AI assistant, reducing practitioner stress and improving patient care. Nabla produces AI-generated clinical notes in seconds from any encounter across all specialties. Powered by proprietary LLMs, fine-tuned to the medical field, Nabla’s capabilities include AI-enabled medical coding identification and smooth EHR integrations.
The company’s leadership includes: Alex Lebrun (CEO), with over two decades of experience building AI products, and whose companies have been acquired by Nuance (VirtuOz) and Facebook (Wit.ai); Delphine Groll (COO) and Martin Raison (CTO). Ed Lee, MD, MPH, who was previously CIO at The Permanente Federation, recently joined Nabla as Chief Medical Officer. He heads Nabla’s Clinical Advisory Board, formed by 20+ seasoned clinical leaders.
On the technological side, the company’s advisors include Yann LeCun, VP & Chief AI Scientist at Meta, and Tony Fadell, inventor of the iPod and former Apple executive, among others.
Nabla has raised a total of $49M, its most recent fundraising being a $30M series B led by global venture capital firm Cathay Innovation. For more information, please visit: www.nabla.com.
Media Contact
nabla@hermespr.co
SOURCE Nabla
Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK /…
SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular…
BEVERLY HILLS, CALIFORNIA / ACCESSWIRE / November 21, 2024 / Nicole Garrett, CEO of Under…
HUNTINGTON BEACH, Calif., Nov. 21, 2024 /PRNewswire/ -- Beacon Healthcare Systems, is pleased to announce…
Attributes Revenue Growth to Innovative Partnerships, Strong Team, and Unique Value-Based Care Model NEW YORK,…
Automation That Makes a Difference SUNRISE, Fla., Nov. 21, 2024 /PRNewswire/ -- When it comes…